Analysts See $-0.95 EPS for Catabasis Pharmaceuticals, Inc. (CATB) | Thorold News - Thorold News
Analysts See $-0.95 EPS for Catabasis Pharmaceuticals, Inc. (CATB) | Thorold News Thorold News
Analysts expect Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) to report $-0.95 EPS on March, 21.They anticipate $1.45 EPS change or 60.42 % from last ...
Comments
Post a Comment